首页|丹栀逍遥散加减方对精神分裂症患者高催乳素血症的影响研究

丹栀逍遥散加减方对精神分裂症患者高催乳素血症的影响研究

扫码查看
目的 观察丹栀逍遥散加减方对精神分裂症患者高催乳素水平的影响.方法 将118 例精神分裂症并发有高催乳血症患者按照随机数字表法分为2 组,2 组均常规给予抗精神分裂症药物治疗,治疗组56 例予丹栀逍遥散加减方治疗,对照组62 例予安慰剂治疗.2 组均治疗12 周后.比较2 组治疗前及治疗 4、12 周血清催乳素、精神症状[采用阳性和阴性症状量表(PANSS)评分进行评价]及生活质量[采用精神分裂症患者生活质量量表(SQLS)进行评价,包括心理社会、动机/精力、症状/副反应 3 个方面]变化情况,统计分析治疗组治疗 12 周后血清催乳素水平与PANSS评分、SQLS评分之间的相关性.结果 与本组治疗前比较,治疗组治疗4、12 周血清催乳素水平均降低(P<0.05),且治疗组治疗4、12 周血清催乳素水平均低于对照组同期(P<0.05),但对照组治疗4、12 周血清催乳素水平与治疗前比较差异均无统计学意义(P>0.05).2 组治疗 4、12 周 PANSS评分与本组治疗前比较及组间比较差异均无统计学意义(P>0.05).与本组治疗前比较,治疗组治疗 4、12 周 SQLS 心理社会、动机/精力、症状/副反应评分及总分均降低(P<0.05),且治疗组治疗4、12 周SQLS心理社会、动机/精力、症状/副反应评分及总分均低于对照组同期(P<0.05),但对照组治疗4、12 周SQLS心理社会、动机/精力、症状/副反应评分及总分与治疗前比较差异均无统计学意义(P>0.05).经Pearson相关性分析显示,治疗组治疗 12 周血清催乳素水平与 SQSL 症状/副反应评分及总分存在正相关性(r = 0.259,P =0.005;r =0.263,P =0.004).结论 丹栀逍遥散加减方治疗精神分裂症患者高催乳素血症临床疗效确切,可有效降低患者血清催乳素水平,提高患者生活质量,是一种颇具治疗效应的临床辅助治疗手段.
Effect of Modified Danzhi Xiaoyao Powder on hyperprolactinemia in schizophrenia patients
Objective To evaluate the effect of modified Danzhi Xiaoyao Powder on hyperprolactinemia in schizophrenia patients.Methods Totally 118 patients with schizophrenia were randomly assigned into a control group(n =62)and a treat-ment group(n =56).All patients were managed by antipsychotics,and the treatment group was treated with modified Danzhi Xi-aoyao Powder,while the control group was treated with placebo,the treatment was performed for 12 weeks for statistical efficacy.Before treatment and after 4 and 12 weeks of treatment,the positive and negative symptom scale(PANSS)scores were performed to evaluate serum prolactin and psychiatric symptoms.The Schizophrenia Quality of Life Scale(SQLS)involving psychosocial,motivation/energy,symptoms/side-effects three subscales was conducted to assess the quality of life.After 12 weeks of treat-ment,the correlation between serum prolactin level and PANSS score and SQLS score in the treatment group was statistically ana-lyzed.Results After treatment,the levels of 4-week and 12-week serum prolactin in the treatment group were significantly de-creased(P<0.05),and which were significantly lower in the treatment group than the control group(P<0.05),but there was no significant difference in serum prolactin between the levels of 4-week and 12-week and that before treatment in the control group(P>0.05).There was no significant difference in PANSS score between the levels of 4-week and 12-week and that be-fore treatment in the both groups(P>0.05).Compared with before treatment,the each dimension scores and total score of 4-week and 12-week SQLS in the treatment group were significantly decreased(P<0.05),and the scores in the treatment group were significantly lower than those in the control group(P<0.05).However,there was no significant difference in the each di-mension scores and total score of 4-week and 12-week SQLS in the control group compared with those before treatment(P>0.05).Pearson correlation analysis showed that there was a positive correlation between 12-week serum prolactin level and SQSL(symptoms/side-effects)score in the treatment group(r =0.259,P =0.005;r =0.263,P =0.004).Conclusion For schizophrenia patients with hyperprolactinemia,modified Danzhi Xiaoyao Powder has a definite clinical efficacy,which can effectively reduce the serum prolactin level and improve the quality of life.It is considered to be a clinical adjuvant therapy with therapeutic effect.

SchizophreniaHyperprolactinemiaChinese medicine therapyDanzhi Xiaoyao Powder

许桦、邢梦娟、孙扬、潘晓鸥、陆颖、吴海苏、朱丽萍、何永光

展开 >

上海交通大学医学院附属精神卫生中心中西医结合科,上海 201108

上海市中医神志病研究所,上海 201108

上海交通大学医学院附属精神卫生中心精神科,上海 201108

精神分裂症 催乳素 中药疗法 丹栀逍遥散

上海市科学技术委员会科研计划项目上海市科学技术委员会科研计划项目上海市科学技术委员会科研计划项目上海市卫生健康委员会中医重点专科培育项目

174019326001640193470010DZ1973300AB83180002019021

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(1)
  • 15